Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Director/PDMR Shareholding

3 Sep 2019 13:00

RNS Number : 0752L
Reckitt Benckiser Group PLC
03 September 2019
 

 

 

 

3 September 2019

 

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

 DIRECTOR/PDMR SHAREHOLDING

 

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

On 2 September 2019 employees were granted options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan (the "Sharesave Plan") with an option price of £47.44. No consideration is payable for the grant of an option. The options are granted in conjunction with the entering into of a three- or five-year savings plan.

 

The Company announces that Laxman Narasimhan, Chief Executive Officer, and Adrian Hennah, Chief Financial Officer, each elected to participate in the 2019 offer under the Sharesave Plan. Laxman was granted an option over 379 Shares, which will become exercisable after three years, on 1 February 2023. Adrian was granted an option over 316 Shares, which will become exercisable after 5 years, on 1 February 2025.

The following notifications are made in accordance with the requirements of the EU Market Abuse Regulation.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Laxman Narasimhan

2

Reason for the notification

a)

Position/status

Executive Director - Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£47.44

379

 

d)

Aggregated information

- Aggregated volume

- Price

Price(s)

Volume(s)

Total

£47.44

379

£17,979.76

e)

Date of the transaction

2019-09-02

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adrian Hennah

2

Reason for the notification

a)

Position/status

Executive Director - Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£47.44

316

 

d)

Aggregated information

- Aggregated volume

- Price

 

Price(s)

Volume(s)

Total

£47.44

316

£14,991.04

e)

Date of the transaction

2019-09-02

f)

Place of the transaction

Outside a trading venue

 

 

For further Information:Christine Logan

Deputy Company SecretaryTel +44 (0) 1753 217 800

 

About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

 

For more information visit www.rb.com

 

 *RB is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBBGDCDXGBGCX
Date   Source Headline
9th Apr 202010:00 amRNSDirectorate Change
6th Apr 202011:42 amRNSAnnual Financial Report
3rd Apr 202010:31 amRNSDirector Declaration
1st Apr 202011:26 amRNSTotal Voting Rights
24th Mar 20204:57 pmRNSDirector/PDMR Shareholding
24th Mar 20204:41 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20205:08 pmRNSDirector/PDMR Shareholding
9th Mar 20204:45 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:26 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:11 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSFull Year Results 2019
3rd Feb 202011:16 amRNSTotal Voting Rights
2nd Jan 202012:20 pmRNSTotal Voting Rights
4th Dec 20191:30 pmRNSDirectorate Change
2nd Dec 201912:00 pmRNSTotal Voting Rights
1st Nov 201912:00 pmRNSTotal Voting Rights
29th Oct 20194:30 pmRNSDirector/PDMR Shareholding
28th Oct 201911:21 amRNSDirector/PDMR Shareholding
24th Oct 20192:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSQ3 2019 Trading Update
21st Oct 201910:15 amRNSDirectorate Change
1st Oct 201911:51 amRNSTotal Voting Rights
30th Sep 20193:12 pmRNSDirector/PDMR Shareholding
18th Sep 201912:00 pmRNSDirectorate Change
3rd Sep 20191:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20191:00 pmRNSDirectorate Change
2nd Sep 201912:37 pmRNSTotal Voting Rights
30th Aug 20193:00 pmRNSDirector/PDMR Shareholding
6th Aug 20192:07 pmRNSDirector/PDMR Shareholding
1st Aug 20199:48 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSHalf Year Results 2019
29th Jul 20199:30 amRNSDirectorate Change
11th Jul 20197:00 amRNSAgreement to resolve all federal investigations
1st Jul 201911:31 amRNSTotal Voting Rights
12th Jun 20197:00 amRNSRB CEO Announcement
3rd Jun 201910:49 amRNSTotal Voting Rights
28th May 201910:40 amRNSDirector/PDMR Shareholding
23rd May 20194:40 pmRNSDirector/PDMR Shareholding
22nd May 201911:45 amRNSDirector/PDMR Shareholding
13th May 20193:01 pmRNSDirector/PDMR Shareholding
9th May 20193:28 pmRNSResult of AGM
2nd May 20197:00 amRNSQ1 Trading Update
1st May 201910:46 amRNSDirectorate Change
1st May 20199:00 amRNSTotal Voting Rights
10th Apr 201910:37 amRNSUS Justice Department indictment of Indivior Plc
4th Apr 201912:45 pmRNSDirector Declaration
2nd Apr 20194:56 pmRNSAnnual Financial Report
1st Apr 20199:30 amRNSTotal Voting Rights
27th Mar 20192:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.